Indication
Ocular itching
Ocular itching, also known as ocular pruritus, is a hallmark symptom of ocular surface hypersensitivity and inflammatory disorders, most notably seasonal and perennial allergic conjunctivitis. Read more about Ocular itching
22 drugs 18 manufacturers
Drugs that treat it
Common Ocular itching therapies.
EYE ALLERGY RELIEF (naphazoline HCl/pheniramine maleate)
NAPHCON-A (naphazoline HCl/pheniramine maleate)
EPINASTINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOcular itching, also known as ocular pruritus, is a hallmark symptom of ocular surface hypersensitivity and inflammatory disorders, most notably seasonal and perennial allergic conjunctivitis.
It affects the conjunctiva and ocular adnexa across both pediatric and adult populations exposed to environmental aeroallergens, irritants, or mechanical friction.
Pathophysiologically, it is primarily driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, wherein allergen binding triggers conjunctival mast cell degranulation and the subsequent release of histamine and other inflammatory mediators.
Histamine subsequently binds to H1 receptors on unmyelinated sensory nerve fibers in the conjunctiva, stimulating the transmission of the itch sensation via the ophthalmic branch of the trigeminal nerve.
- nih.gov
Ocular itching, also known as ocular pruritus, is a hallmark symptom of ocular surface hypersensitivity and inflammatory disorders, most notably seasonal and perennial allergic conjunctivitis It affects the conjunctiva and ocular adnexa across both pediatric and adult populations exposed to environmental aeroallergens, irritants, or mechanical friction Histamine subsequently binds to H1 receptors on unmyelinated sensory nerve fibers in the conjunctiva, stimulating the transmission of the itch se...
- drugbank.com
Ocular itching, also known as ocular pruritus, is a hallmark symptom of ocular surface hypersensitivity and inflammatory disorders, most notably seasonal and perennial allergic conjunctivitis
- nih.gov
It affects the conjunctiva and ocular adnexa across both pediatric and adult populations exposed to environmental aeroallergens, irritants, or mechanical friction Pathophysiologically, it is primarily driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, wherein allergen binding triggers conjunctival mast cell degranulation and the subsequent release of histamine and other inflammatory mediators
- fda.gov
It affects the conjunctiva and ocular adnexa across both pediatric and adult populations exposed to environmental aeroallergens, irritants, or mechanical friction
- nih.gov
Pathophysiologically, it is primarily driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, wherein allergen binding triggers conjunctival mast cell degranulation and the subsequent release of histamine and other inflammatory mediators
- nih.gov
Pathophysiologically, it is primarily driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, wherein allergen binding triggers conjunctival mast cell degranulation and the subsequent release of histamine and other inflammatory mediators
- nih.gov
Histamine subsequently binds to H1 receptors on unmyelinated sensory nerve fibers in the conjunctiva, stimulating the transmission of the itch sensation via the ophthalmic branch of the trigeminal nerve
Personalize your experience
Follow Ocular itching and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.